Skip to main content
SpringerLink
Log in

Multivalent Vaccine Studies for HTLV-1 Associated Diseases

  • Chapter
Peptides: The Wave of the Future

Part of the book series: American Peptide Symposia ((APSY,volume 7))

  • 56 Accesses

Abstract

Human T-cell Lymphotropic Virus Type-1 is the causative agent of Adult T-cell Leukemia (ATL) and HTLV-1 associated Myelopathy or Tropical Spastic Paraparesis (HAM/TSP). In addition, HTLV-1 has been implicated in a variety of other inflammatory disorders. Natural immune responses to the virus, mainly against the envelope protein have been detected in infected individuals [1], HTLV-1 also displays very low genomic and antigenic variation making it an attractive candidate for vaccine studies [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Bangham, C.R. J. Clin. Pathol. 53, 581–586 (2000).

    Article  CAS  PubMed  Google Scholar 

  2. Agadjanyan, M.G., Wang, B., Nyland, S.B., Weiner, D.B., Ugen, K.E. Curr. Top. Microbiol. Immunol. 226, 175–192 (1998).

    CAS  PubMed  Google Scholar 

  3. Kaumaya, P.T.P., Kobs-Conrad, S., DiGeorge, A.M., Stevens, V. Peptides: Des. Synth. Biol. 9, 133–164 (1994).

    Google Scholar 

  4. Frangione-Beebe, M., Albrecht, B., Dakappagari, N., Rose, R.T., Brooks, C.L., Schwendeman, S.P., Lairmore, M.D., Kaumaya, P.T. Vaccine 19, 1068–1081 (2000).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Medicine, The Ohio State University, Columbus, OH, 43210, USA

    Pravin T. P. Kaumaya

  2. The Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA

    Pravin T. P. Kaumaya

  3. Department of Obstetrics and Gynecology, The Ohio State University, Columbus, OH, 43210, USA

    Roshni Sundaram & Pravin T. P. Kaumaya

  4. Molecular and Cellular Biochemistry, The Ohio State University, Columbus, OH, 43210, USA

    Pravin T. P. Kaumaya

  5. Department of Microbiology, The Ohio State University, Columbus, OH, 43210, USA

    Roshni Sundaram & Pravin T. P. Kaumaya

Authors
  1. Roshni Sundaram
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pravin T. P. Kaumaya
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Spyder Instruments, Inc. and Illumina, Inc., 9885 Towne Centre Drive, 92121, San Diego, CA, USA

    Michal Lebl

  2. Torrey Pines Institute for Molecular Studies, Mixture Sciences, Inc., 3550 General Atomics Court, 92121, San Diego, CA, USA

    Richard A. Houghten

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Sundaram, R., Kaumaya, P.T.P. (2001). Multivalent Vaccine Studies for HTLV-1 Associated Diseases. In: Lebl, M., Houghten, R.A. (eds) Peptides: The Wave of the Future. American Peptide Symposia, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0464-0_470

Download citation

  • DOI: https://doi.org/10.1007/978-94-010-0464-0_470

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-3905-5

  • Online ISBN: 978-94-010-0464-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation